Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meek, S. E.
Right arrow Articles by Jensen, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meek, S. E.
Right arrow Articles by Jensen, M. D.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 48, Issue 1 10-14, Copyright © 1999 by American Diabetes Association


ARTICLES

Insulin regulation of regional free fatty acid metabolism

SE Meek, KS Nair and MD Jensen
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA.

Studies were conducted to determine whether regional free fatty acid (FFA) release is differentially regulated by insulin. Systemic, leg, and splanchnic palmitate rate of appearance ([9,10-(3)H]palmitate) was measured in 26 healthy adults using the euglycemic-hyperinsulinemic clamp technique to achieve a physiological range of plasma insulin concentrations. We found that insulin inhibited systemic, leg, and splanchnic palmitate release in a dose-dependent fashion over the range of insulin infused (0-1.0 mU x kg(-1) x min(-1)). Progressive hyperinsulinemia changed the leg from a net producer to a net FFA consumer, whereas the splanchnic bed converted from a net FFA consumer to a net producer. At the 0.5 mU x kg(-1) x min(-1) insulin infusion rate, leg FFA release was almost completely suppressed, whereas even with the 1.0 mU x kg(-1) x min(-1) insulin infusion rate, splanchnic FFA release decreased by only approximately 65% (P < 0.05 leg vs. splanchnic). These results demonstrate the regional heterogeneity of insulin-regulated FFA release in vivo, and indicate that visceral adipose tissue lipolysis is more resistant to insulin suppression than is leg lipolysis in humans.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
E. L. Melanson, W. T. Donahoo, G. K. Grunwald, and R. Schwartz
Changes in 24-h substrate oxidation in older and younger men in response to exercise
J Appl Physiol, November 1, 2007; 103(5): 1576 - 1582.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. Hodson, A. S.T. Bickerton, S. E. McQuaid, R. Roberts, F. Karpe, K. N. Frayn, and B. A. Fielding
The Contribution of Splanchnic Fat to VLDL Triglyceride Is Greater in Insulin-Resistant Than Insulin-Sensitive Men and Women: Studies in the Postprandial State
Diabetes, October 1, 2007; 56(10): 2433 - 2441.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Shadid, C. Koutsari, and M. D. Jensen
Direct Free Fatty Acid Uptake Into Human Adipocytes In Vivo: Relation to Body Fat Distribution
Diabetes, May 1, 2007; 56(5): 1369 - 1375.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Lafontan, C. Moro, C. Sengenes, J. Galitzky, F. Crampes, and M. Berlan
An Unsuspected Metabolic Role for Atrial Natriuretic Peptides: The Control of Lipolysis, Lipid Mobilization, and Systemic Nonesterified Fatty Acids Levels in Humans
Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2032 - 2042.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Gastaldelli, Y. Miyazaki, M. Pettiti, E. Buzzigoli, S. Mahankali, E. Ferrannini, and R. A. DeFronzo
Separate Contribution of Diabetes, Total Fat Mass, and Fat Topography to Glucose Production, Gluconeogenesis, and Glycogenolysis
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3914 - 3921.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Basu, A. Basu, C. M. Johnson, W. F. Schwenk, and R. A. Rizza
Insulin Dose-Response Curves for Stimulation of Splanchnic Glucose Uptake and Suppression of Endogenous Glucose Production Differ in Nondiabetic Humans and Are Abnormal in People With Type 2 Diabetes
Diabetes, August 1, 2004; 53(8): 2042 - 2050.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Basu, R. J. Singh, A. Basu, E. G. Chittilapilly, C. M. Johnson, G. Toffolo, C. Cobelli, and R. A. Rizza
Splanchnic Cortisol Production Occurs in Humans: Evidence for Conversion of Cortisone to Cortisol Via the 11-{beta} Hydroxysteroid Dehydrogenase (11{beta}-HSD) Type 1 Pathway
Diabetes, August 1, 2004; 53(8): 2051 - 2059.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. P. Kim, M. Ellmerer, G. W. Van Citters, and R. N. Bergman
Primacy of Hepatic Insulin Resistance in the Development of the Metabolic Syndrome Induced by an Isocaloric Moderate-Fat Diet in the Dog
Diabetes, October 1, 2003; 52(10): 2453 - 2460.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. N. Reeds, B. Mittendorfer, B. W. Patterson, W. G. Powderly, K. E. Yarasheski, and S. Klein
Alterations in lipid kinetics in men with HIV-dyslipidemia
Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E490 - E497.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. D. Jensen, S. Cardin, D. Edgerton, and A. Cherrington
Splanchnic free fatty acid kinetics
Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1140 - E1148.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Gastaldelli, Y. Miyazaki, M. Pettiti, M. Matsuda, S. Mahankali, E. Santini, R. A. DeFronzo, and E. Ferrannini
Metabolic Effects of Visceral Fat Accumulation in Type 2 Diabetes
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5098 - 5103.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. D. Riis, C. H. Gravholt, C. B. Djurhuus, H. Norrelund, J. O. L. Jorgensen, J. Weeke, and N. Moller
Elevated Regional Lipolysis in Hyperthyroidism
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4747 - 4753.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. D. Mittelman, G. W. Van Citters, E. L. Kirkman, and R. N. Bergman
Extreme Insulin Resistance of the Central Adipose Depot In Vivo
Diabetes, March 1, 2002; 51(3): 755 - 761.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Mittendorfer, J. F. Horowitz, and S. Klein
Gender differences in lipid and glucose kinetics during short-term fasting
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1333 - E1339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Basu, R. Basu, P. Shah, A. Vella, R. A. Rizza, and M. D. Jensen
Systemic and regional free fatty acid metabolism in type 2 diabetes
Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E1000 - E1006.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. Aline Charles, A. Fontbonne, N. Thibult, J.-R. Claude, J.-M. Warnet, G. Rosselin, P. Ducimetiere, and E. Eschwege
High Plasma Nonesterified Fatty Acids Are Predictive of Cancer Mortality but Not of Coronary Heart Disease Mortality: Results from the Paris Prospective Study
Am. J. Epidemiol., February 1, 2001; 153(3): 292 - 298.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Stumvoll, S. Jacob, H. G. Wahl, B. Hauer, K. Löblein, P. Grauer, R. Becker, M. Nielsen, W. Renn, and H. Häring
Suppression of Systemic, Intramuscular, and Subcutaneous Adipose Tissue Lipolysis by Insulin in Humans
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3740 - 3745.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
R. Ross, D. Dagnone, P. J.H. Jones, H. Smith, A. Paddags, R. Hudson, and I. Janssen
Reduction in Obesity and Related Comorbid Conditions after Diet-Induced Weight Loss or Exercise-Induced Weight Loss in Men: A Randomized, Controlled Trial
Ann Intern Med, July 18, 2000; 133(2): 92 - 103.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1999 by the American Diabetes Association.